Nasdaq

Eisai: Metoject Subcutaneous Injection Pen (Methotrexate) Pen-Type Autoinjector Approved in Japan

TOKYO, Feb 16, 2024 - (JCN Newswire) - - Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac Gesellschaft fur klinische Spezialpraparate mbH announced that they have obtained ...
Pharmabiz

Eisai, nippon medac get Japanese marketing approval for Metoject subcutaneous injection pen (methotrexate) pen-type autoinjector

Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac Gesellschaft für klinische Spezialpräparate mbH announced that they have obtained manufacturing and marketing approval from the ...
Yahoo Finance

Hyphens Pharma’s subsidiary extends partnership to commercialise autoinjector pen in Thailand and Cambodia

The group partnered with Medac Gesellschaft für klinische Spezialpräparate for the exclusive rights to commercialise the subcutaneous autoinjector pen in Singapore, Malaysia, Vietnam and Philippines.
Mena FN

Eisai: Metoject Subcutaneous Injection Pen (Methotrexate) Pen-Type Autoinjector Launched In Japan

TOKYO, May 22, 2024 - (JCN Newswire) - Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac group announced today that they have launched the anti-rheumatic agent“Metoject® Subcutaneous ...